Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
[Preprint]. 2025 Mar 11:2025.03.11.642547.
doi: 10.1101/2025.03.11.642547.

Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial

Affiliations

Assessment of ecological fidelity of human microbiome-associated mice in observational studies and an interventional trial

Matthew K Wong et al. bioRxiv. .

Update in

Abstract

Composition and function of the gut microbiome is associated with diverse health conditions and treatment responses. Human microbiota-associated (HMA) mouse models are used to establish causal links for these associations but have important limitations. We assessed the fidelity of HMA mouse models to recapitulate ecological responses to a microbial consortium using stools collected from a human clinical trial. HMA mice were generated using different routes of consortium exposure and their ecological features were compared to human donors by metagenomic sequencing. HMA mice were more similar in gut composition to other mice than their respective human donors, with taxa including Akkermansia muciniphila and Bacteroides species enriched in mouse recipients. A limited repertoire of microbes was able to engraft into HMA mice regardless of route of consortium exposure. In publicly available HMA mouse datasets from four distinct health conditions, we confirmed our observation that a taxonomically restricted set of microbes reproducibly engrafts in HMA mice and observed that stool microbiome composition of HMA mice were more like other mice than their human donor. Our data suggest that HMA mice are limited models to assess the ecological impact of microbial consortia, with ecological effects in HMA mice being more strongly associated with host species than donor stool ecology or ecological responses to treatment in humans. Comparisons to published studies suggest this may be due to comparatively large host-species effects that overwhelm ecological effects of treatment in humans that HMA models aim to recapitulate.

Keywords: fecal microbiota transplant; gut microbiome; human microbiota-associated mice; microbial consortia.

PubMed Disclaimer

Conflict of interest statement

Competing Interests: AS has consulting/advisory arrangements with Merck, Bristol-Myers Squibb, Novartis, Oncorus, Janssen, Medison & Immunocore. The institution receives clinical trial support from: Novartis, BristolMyers Squibb, Symphogen AstraZeneca/Medimmune, Merck, Bayer, Surface Oncology, Northern Biologics, Janssen Oncology/Johnson & Johnson, Roche, Regeneron, Alkermes, Array Biopharma/Pfizer, GSK, Treadwell, ALX Oncology, Amgen, Servier. LLS has consulting/advisory arrangements with Merck, Pfizer, AstraZeneca, Roche, Symphogen, Seattle Genetics, GlaxoSmithKline, Voroni, Arvinas, Tessa, Navire, Relay, Rubius, Janpix, Daiichi Sanyko, Coherus, Marengo, InterRNA; stock ownership of Agios (spouse); leadership positions in Treadwell Therapeutics (spouse); and institution receives clinical trials support from Novartis, Bristol-Myers Squibb, Pfizer, Boerhinger-Ingelheim, GlaxoSmithKline, Roche/Genentech, Kayropharm, AstraZeneca, Merck, Celgene, Astellas, Bayer, Abbvie, Amgen, Nubiyota, Symphogen, Intensity Therapeutics, Shattucks. KC and KS were employed by Nubiyota. EAV is co-founder and CSO of NuBiyota LLC. All other authors have declared no conflicts of interest.

Figures

Figure 1.
Figure 1.. Different gut microbiota engraft in mouse recipients compared to human donors.
(A) Flowchart depicting generation of HMA mice. (B) Principal coordinate analysis plot for Bray-Curtis dissimilarity between human donor and mouse stool composition. Each dot is an individual human donor sample or an average of mouse recipient samples from the same donor. PERMANOVA compares species composition. (C) Bray-Curtis dissimilarity for all comparisons between donors, mice, and between donor and respective recipients. Lines indicate the mean and whiskers are standard deviation. Kruskal-Wallis test followed by Dunn’s multiple comparisons test performed. (D) Association between species and relative abundance of stool taxa in human donors and recipient mice, including donor ID and treatment timepoint as random effects. Blue shading indicates taxa enriched in mice, while red indicates taxa enriched in humans. Statistics and coefficients determined with MaAsLin2. Heatmap displays the log % relative abundance of corresponding taxa in individual human and mouse samples. Zero values are arbitrarily set to −3. (E) Scatter plot of delta % relative abundance (RA) for stool taxa from baseline to post-MET4 timepoints in human donors and mouse recipients. Each dot represents an individual taxon, and only taxa overlapping between humans and mice were included. Percent of overlapping taxa is shown for each quadrant. Pearson’s correlation test was performed.
Figure 2.
Figure 2.. Analysis of the gut microbiome following different treatment exposure routes in germ-free mice.
(A) Diagram describing the two routes of treatment exposure in this study. Stools were collected at the indicated timepoints. (B) Principal coordinate analysis plot (PCoA) of Bray-Curtis dissimilarity for MET4, donor stools, and stool from mouse recipients receiving donor FMT and/or direct MET4 administration. Each dot represents an individual human donor sample, an average of MET4 samples sequenced, or an average of mouse recipient stools from the same donor and treatment route. Diamonds represent T0 timepoints, triangles represent T2, and square represents MET4. PERMANOVA compares MET4, donor stool, and mouse recipient stool composition. (C-D) Average relative abundance (%) histograms for stools from mice receiving post-MET4 (T2) donor stool from B004 (D) and B005 (E) or MET4 directly. Donor stool composition is included as a comparator. Non-MET4 taxa are in grayscale and unlabeled. “Other” consists of taxa with <5% relative abundance in every sample. (E-F) Scatter plots showing logscale % relative abundance of gut taxa in B004 (F) and B005 (G) mice compared between routes of exposure at T2. Each point represents a different taxon. MET4 taxa are represented by green triangles.
Figure 3.
Figure 3.. HMA mice engraft specific taxa more consistently.
(A) Heat map displaying correlation coefficient for relative abundance (RA) of all taxa between studies and species. (B) Comparison of Z-transformed correlation coefficients by ANOVA followed by Tukey’s multiple comparisons test. (C) Principal coordinate analysis plot (PCoA) of Bray Curtis dissimilarity comparing HMA mice to human donors from different studies. Each dot represents a human donor or an average of mouse recipient stools. Circles represent humans, squares represent mice. PERMANOVA compares species composition. (D) Bray-Curtis dissimilarity for all comparisons between donors, mice, and between donor and respective recipients. Kruskal-Wallis test followed by Dunn’s multiple comparisons test performed. (E) Percent (%) engraftment of taxa from HMA mouse study human donors into recipient mice. Only taxa engrafting in >4 mice are included. Each dot represents % engraftment of one taxon in individual studies and lines represent the mean across taxa within the study. Taxa were stratified into high, medium, or low engrafters based on average % engraftment across studies. (F-G) Scatter plots of % engraftment against average mouse RA across HMA mouse studies (F) or average mouse RA of MET4 taxa in mice exposed to MET4 (G). Each dot represents an individual taxon. MET4 taxa are labeled and are represented by triangles. Coloured taxa in (F) correspond to high, medium, or low engraftment from (E). Lines represent mean and whiskers represent the standard deviation in all figures. IBD – intestinal bowel disease; PD – Parkinson’s disease; CRC – colorectal cancer; ASD – autism spectrum disorder

References

    1. Arrieta M. C., Walter J., and Finlay B. B.. 2016. Human Microbiota-Associated Mice: A Model with Challenges. Cell Host Microbe 19: 575–578. - PubMed
    1. Walter J., Armet A. M., Finlay B. B., and Shanahan F.. 2020. Establishing or Exaggerating Causality for the Gut Microbiome: Lessons from Human Microbiota-Associated Rodents. Cell 180: 221–232. - PubMed
    1. Nguyen T. L. A., Vieira-Silva S., Liston A., and Raes J.. 2015. How informative is the mouse for human gut microbiota research? DMM Disease Models and Mechanisms 8: 1–16. - PMC - PubMed
    1. Park J. C., and Im S. H.. 2020. Of men in mice: the development and application of a humanized gnotobiotic mouse model for microbiome therapeutics. Exp Mol Med 52: 1383–1396. - PMC - PubMed
    1. Petrof E. O., Claud E. C., Gloor G. B., and Allen-Vercoe E.. 2013. Microbial ecosystems therapeutics: A new paradigm in medicine? Benef Microbes 4: 53–65. - PubMed

Publication types

LinkOut - more resources